Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 29, 2003. The report primarily details corporate actions regarding share buybacks and updates on directors' interests in company shares held through various employee benefit trusts and plans.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to a share repurchase transaction:
- Shares Repurchased: 790,000 Ordinary 25 pence shares.
- Repurchase Price: 1,264.35 pence per share.
- Transaction Date: September 26, 2003.
Material Changes
The filing reports the following material changes and transactions:
- Share Cancellation: The company purchased 790,000 shares for cancellation under authority granted at the May 19, 2003 Annual General Meeting.
- US Retirement Savings Plan: The number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan decreased from 18,882,865 to 18,805,362 due to fund movements on September 25, 2003, at an average price of $42.38.
- Employee Trust Transfers:
- 20,392 Ordinary Shares were transferred from the GlaxoSmithKline Employee Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- 1,120 Ordinary Shares were transferred from the SmithKline Beecham Employee Benefit Trust to a participant in the SmithKline Beecham Bonus Investment Plan.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. It notes that directors Dr. J-P Garnier and Mr. J.D. Coombe hold potential interests in shares held within the various discretionary employee trusts and funds mentioned, similar to other employees.
Investor Verification Checklist
- Verify the total number of shares repurchased for cancellation in the 2003 fiscal year to date.
- Confirm the impact of the share buyback on the company's total share count and earnings per share.
- Review the full details of the GlaxoSmithKline US Retirement Savings Plan and Employee Trusts to understand the extent of director interests.
- Check subsequent filings for the full quarterly or annual financial results, as this 6-K does not contain them.